NO994041L - Nye indan-l-ol forbindelser, en fremgangsmÕte for Õ behandle dem og farmasøytiske forbindelser inneholdende dem - Google Patents

Nye indan-l-ol forbindelser, en fremgangsmÕte for Õ behandle dem og farmasøytiske forbindelser inneholdende dem

Info

Publication number: NO994041L
Authority: NO; Norway
Prior art keywords: compounds; treating; procedure; alkyl; trihaloalkyl
Prior art date: 1998-08-21

Application number

NO994041A

Other languages

English (en)

Other versions

NO994041D0 (no

NO317516B1 (no

Inventor

Jean-Louis Peglion

Bertrand Goument

Mark Millan

Adrian Newman-Tancredi

Original Assignee

Adir

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-08-21

Filing date

1999-08-20

Publication date

2000-02-22

1999-08-20 Application filed by Adir filed Critical Adir

1999-08-20 Publication of NO994041D0 publication Critical patent/NO994041D0/no

2000-02-22 Publication of NO994041L publication Critical patent/NO994041L/no

2004-11-08 Publication of NO317516B1 publication Critical patent/NO317516B1/no

Links

150000001875 compounds Chemical class 0.000 title abstract 2
YIAPLDFPUUJILH-UHFFFAOYSA-N indan-1-ol Chemical class C1=CC=C2C(O)CCC2=C1 YIAPLDFPUUJILH-UHFFFAOYSA-N 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 3
150000002431 hydrogen Chemical class 0.000 abstract 3
229910052739 hydrogen Inorganic materials 0.000 abstract 3
239000001257 hydrogen Substances 0.000 abstract 3
125000003545 alkoxy group Chemical group 0.000 abstract 2
229910052736 halogen Inorganic materials 0.000 abstract 2
150000002367 halogens Chemical class 0.000 abstract 2
125000000623 heterocyclic group Chemical group 0.000 abstract 2
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
125000004385 trihaloalkyl group Chemical group 0.000 abstract 2
102100027499 5-hydroxytryptamine receptor 1B Human genes 0.000 abstract 1
101150050738 HTR1B gene Proteins 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
125000003342 alkenyl group Chemical group 0.000 abstract 1
125000000304 alkynyl group Chemical group 0.000 abstract 1
125000003710 aryl alkyl group Chemical group 0.000 abstract 1
229940126601 medicinal product Drugs 0.000 abstract 1
230000007170 pathology Effects 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Psychiatry (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Child & Adolescent Psychology (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)

NO19994041A 1998-08-21 1999-08-20 Nye indan-l-ol forbindelser, en fremgangsmate for a behandle dem og farmasoytiske forbindelser inneholdende dem NO317516B1 (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9810601A FR2782515B1 (fr)	1998-08-21	1998-08-21	NOUVEAUX DERIVES DE L'INDANE-1-Ol, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT

Publications (3)

Publication Number	Publication Date
NO994041D0 NO994041D0 (no)	1999-08-20
NO994041L true NO994041L (no)	2000-02-22
NO317516B1 NO317516B1 (no)	2004-11-08

Family

ID=9529811

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19994041A NO317516B1 (no)	1998-08-21	1999-08-20	Nye indan-l-ol forbindelser, en fremgangsmate for a behandle dem og farmasoytiske forbindelser inneholdende dem

Country Status (18)

Country	Link
US (1)	US6153625A (no)
EP (1)	EP0982305B1 (no)
JP (1)	JP2000072748A (no)
CN (1)	CN1128144C (no)
AT (1)	ATE214064T1 (no)
AU (1)	AU747494B2 (no)
BR (1)	BR9903867A (no)
CA (1)	CA2280596A1 (no)
DE (1)	DE69900961T2 (no)
DK (1)	DK0982305T3 (no)
ES (1)	ES2172294T3 (no)
FR (1)	FR2782515B1 (no)
HU (1)	HUP9902784A3 (no)
NO (1)	NO317516B1 (no)
NZ (1)	NZ337362A (no)
PL (1)	PL194852B1 (no)
PT (1)	PT982305E (no)
ZA (1)	ZA995321B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE0103647D0 (sv) *	2001-11-01	2001-11-01	Astrazeneca Ab	Therapeutic chromone compounds
NZ535574A (en) *	2001-01-16	2006-07-28	Astrazeneca Ab	Therapeutic heterocyclic compounds
CA2434015A1 (en) *	2001-01-16	2002-07-18	Astrazeneca Ab	Therapeutic chroman compounds
MXPA03006268A (es) *	2001-01-16	2003-09-22	Astrazeneca Ab	Compuestos terapeuticos de cromano.
SE0103646D0 (sv) *	2001-11-01	2001-11-01	Astrazeneca Ab	Therapeutic chroman compounds
DE10142661B4 (de) *	2001-08-31	2004-06-09	Aventis Pharma Deutschland Gmbh	Mehrfach substituierte Indan-1-ol-Systeme und ihre Verwendung als Arzneimittel
DE10142662B4 (de)	2001-08-31	2004-07-08	Aventis Pharma Deutschland Gmbh	Derivate von C2-substituierten Indan-1-ol-Systemen und ihre Verwendung als Arzneimittel
DE10142667B4 (de) *	2001-08-31	2004-06-09	Aventis Pharma Deutschland Gmbh	C2-substituierte Indan-1-ole und ihre Derivate und ihre Verwendung als Arzneimittel
UY29892A1 (es) *	2005-11-04	2007-06-29	Astrazeneca Ab	Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones
CN116283657B (zh) *	2023-02-22	2024-08-20	贵州大学	一种茚酮衍生物及其合成方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2681325B1 (fr) *	1991-09-16	1993-12-17	Fabre Medicament Pierre	Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique.
GB9318431D0 (en) *	1993-09-06	1993-10-20	Boots Co Plc	Therapeutic agents
FR2761358B1 (fr) *	1997-03-27	1999-05-07	Adir	Nouveaux composes de n-aryl piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

1998
- 1998-08-21 FR FR9810601A patent/FR2782515B1/fr not_active Expired - Fee Related
1999
- 1999-08-13 US US09/374,161 patent/US6153625A/en not_active Expired - Fee Related
- 1999-08-19 JP JP11232097A patent/JP2000072748A/ja active Pending
- 1999-08-19 HU HU9902784A patent/HUP9902784A3/hu unknown
- 1999-08-20 ZA ZA9905321A patent/ZA995321B/xx unknown
- 1999-08-20 PT PT99402092T patent/PT982305E/pt unknown
- 1999-08-20 BR BR9903867-6A patent/BR9903867A/pt not_active Application Discontinuation
- 1999-08-20 NZ NZ337362A patent/NZ337362A/xx unknown
- 1999-08-20 CA CA002280596A patent/CA2280596A1/fr not_active Abandoned
- 1999-08-20 PL PL335012A patent/PL194852B1/pl not_active IP Right Cessation
- 1999-08-20 DK DK99402092T patent/DK0982305T3/da active
- 1999-08-20 AU AU44637/99A patent/AU747494B2/en not_active Ceased
- 1999-08-20 NO NO19994041A patent/NO317516B1/no unknown
- 1999-08-20 DE DE69900961T patent/DE69900961T2/de not_active Expired - Fee Related
- 1999-08-20 AT AT99402092T patent/ATE214064T1/de not_active IP Right Cessation
- 1999-08-20 CN CN99119425A patent/CN1128144C/zh not_active Expired - Fee Related
- 1999-08-20 ES ES99402092T patent/ES2172294T3/es not_active Expired - Lifetime
- 1999-08-20 EP EP99402092A patent/EP0982305B1/fr not_active Expired - Lifetime

Also Published As

Publication number	Publication date
PL335012A1 (en)	2000-02-28
NZ337362A (en)	2000-04-28
HK1026212A1 (en)	2000-12-08
NO994041D0 (no)	1999-08-20
CN1250051A (zh)	2000-04-12
ES2172294T3 (es)	2002-09-16
JP2000072748A (ja)	2000-03-07
ZA995321B (en)	2000-02-22
US6153625A (en)	2000-11-28
DE69900961D1 (de)	2002-04-11
CN1128144C (zh)	2003-11-19
EP0982305B1 (fr)	2002-03-06
PL194852B1 (pl)	2007-07-31
FR2782515A1 (fr)	2000-02-25
CA2280596A1 (fr)	2000-02-21
ATE214064T1 (de)	2002-03-15
FR2782515B1 (fr)	2000-09-22
HUP9902784A3 (en)	2001-03-28
AU4463799A (en)	2000-03-09
DE69900961T2 (de)	2002-11-07
DK0982305T3 (da)	2002-06-24
NO317516B1 (no)	2004-11-08
HUP9902784A2 (hu)	2000-12-28
EP0982305A1 (fr)	2000-03-01
BR9903867A (pt)	2000-09-05
HU9902784D0 (en)	1999-10-28
AU747494B2 (en)	2002-05-16
PT982305E (pt)	2002-07-31

Publication	Publication Date	Title
SE9903998D0 (sv)	1999-11-03	New compounds
ATE296826T1 (de)	2005-06-15	Pyrazolo(1,5)pyridinderivate
DK1519724T3 (da)	2010-01-04	Fredericamycin-derivater som lægemidler til behandling af tumorer
NO20050525L (no)	2005-05-06	Benzimidazol-1-yl-tiofenforbindelser for behandling av cancer
NO20051339L (no)	2005-05-03	Anvendelse av lkB-kinaseinbibitorer ved behandling av smerte.
MXPA04005886A (es)	2004-09-13	Derivados de azaindolilalquilamina como ligandos de 5-hidroxitirptamina-6.
NZ511927A (en)	2004-02-27	Phenylglycine derivatives
PT1263724E (pt)	2005-09-30	Novos compostos
ATE433447T1 (de)	2009-06-15	Pyrimiidinverbindungen
PT1200412E (pt)	2004-04-30	Agentes anti-proliferativos de imidazole
ATE301653T1 (de)	2005-08-15	Pyrazolopyridine
ATE300541T1 (de)	2005-08-15	Pyrazolopyridinderivate
SE9903997D0 (sv)	1999-11-03	New compounds
NO994041D0 (no)	1999-08-20	Nye indan-l-ol forbindelser, en fremgangsmÕte for Õ behandle dem og farmasöytiske forbindelser inneholdende dem
DE60115466D1 (de)	2006-01-05	Wirkstoffvorläufer von imidazopyridin-derivaten
SE9804212D0 (sv)	1998-12-04	Compounds
EE9900450A (et)	2000-04-17	Tetrahüdropüridoühendid, neid sisaldav ravim ja nende kasutamine
NZ545580A (en)	2009-03-31	Aminoquinoline derivatives and their use as adenosine A3 ligands
DE69933885D1 (de)	2006-12-14	Triphenylbutenderivate zur behandlung von neurologischen störungen
DK1109560T3 (da)	2003-11-03	Som AICARFT-inhibitorer anvendelige forbindelser
DE60222465D1 (de)	2007-10-25	Pyrazolopyridin-derivate als antiherpesmittel
ATE274515T1 (de)	2004-09-15	Pyrazolopyridinderivate
ES455741A1 (es)	1978-04-16	Un procedimiento para la preparacion de nuevos derivados de 1,3-bencenodimetanol.
ATE346040T1 (de)	2006-12-15	Aryl-sulfonamide als serotonin-antagonisten für de behandlung von fettleibigkeit
DE60010934D1 (de)	2004-06-24	Medikamente geeignet zur Behandlung von proliferativen Erkrankungen